Drug Type Gene therapy |
Synonyms SP 105, SP-105, SP105 |
Target |
Action inhibitors, stimulants |
Mechanism COX-2 inhibitors(Cyclooxygenase-2 inhibitors), Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Basal Cell Carcinoma | Phase 1 | Australia | 07 Feb 2022 | |
Cutaneous Squamous Cell Carcinoma | Phase 1 | Australia | 07 Feb 2022 | |
Neoplasms | Preclinical | United States | 12 Apr 2024 |
Not Applicable | - | ufcpkrompw(ljxndaedlv) = auyiexhwtc xspaoxbjve (rfogxwfvni ) View more | Positive | 26 May 2017 |